Histogen Inc. ( HSTO) - Key Metrics
Stock symbol HSTO is outdated, potentially delisted? Maybe it is available on other exchange?
HSTO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q3 | $0 | -$0.90 | -$0.63 | -$0.63 |
| 2023Q2 | $0 | -$0.49 | -$0.56 | -$0.56 |
| 2023Q1 | $0 | -$0.81 | -$0.60 | -$0.60 |
| 2022Q4 | $0 | -$0.93 | -$0.76 | -$0.76 |
| 2022Q3 | $0 | -$1.01 | -$0.69 | -$0.69 |
HSTO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q3 | ? | -0.14 |
| 2023Q2 | ? | -0.36 |
| 2023Q1 | ? | -0.37 |
| 2022Q4 | ? | -0.22 |
| 2022Q3 | ? | -0.33 |
HSTO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2023Q3 | -122.32% | ? |
| 2023Q2 | -79.00% | ? |
| 2023Q1 | -49.33% | ? |
| 2022Q4 | -91.55% | ? |
| 2022Q3 | -51.24% | ? |
HSTO
Price: $0.02
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.81 USD
P/E Ratio: -0.12
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 31330
Market Capitalization: 897069